全文获取类型
收费全文 | 123283篇 |
免费 | 8054篇 |
国内免费 | 535篇 |
专业分类
耳鼻咽喉 | 1313篇 |
儿科学 | 3632篇 |
妇产科学 | 2062篇 |
基础医学 | 16385篇 |
口腔科学 | 2207篇 |
临床医学 | 12183篇 |
内科学 | 26093篇 |
皮肤病学 | 1479篇 |
神经病学 | 11958篇 |
特种医学 | 3814篇 |
外国民族医学 | 1篇 |
外科学 | 17699篇 |
综合类 | 1658篇 |
现状与发展 | 1篇 |
一般理论 | 156篇 |
预防医学 | 10744篇 |
眼科学 | 3319篇 |
药学 | 8722篇 |
1篇 | |
中国医学 | 278篇 |
肿瘤学 | 8167篇 |
出版年
2023年 | 609篇 |
2022年 | 1066篇 |
2021年 | 2368篇 |
2020年 | 1410篇 |
2019年 | 2401篇 |
2018年 | 2803篇 |
2017年 | 2039篇 |
2016年 | 2379篇 |
2015年 | 2743篇 |
2014年 | 3958篇 |
2013年 | 5557篇 |
2012年 | 8470篇 |
2011年 | 9095篇 |
2010年 | 4966篇 |
2009年 | 4631篇 |
2008年 | 8024篇 |
2007年 | 8514篇 |
2006年 | 8070篇 |
2005年 | 8121篇 |
2004年 | 7666篇 |
2003年 | 7067篇 |
2002年 | 6816篇 |
2001年 | 1192篇 |
2000年 | 890篇 |
1999年 | 1228篇 |
1998年 | 1452篇 |
1997年 | 1224篇 |
1996年 | 949篇 |
1995年 | 945篇 |
1994年 | 799篇 |
1993年 | 786篇 |
1992年 | 664篇 |
1991年 | 607篇 |
1990年 | 540篇 |
1989年 | 501篇 |
1988年 | 502篇 |
1987年 | 484篇 |
1986年 | 419篇 |
1985年 | 497篇 |
1984年 | 562篇 |
1983年 | 522篇 |
1982年 | 697篇 |
1981年 | 610篇 |
1980年 | 534篇 |
1979年 | 368篇 |
1978年 | 347篇 |
1977年 | 348篇 |
1976年 | 291篇 |
1975年 | 272篇 |
1974年 | 279篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
Steven J Lobritto Philip Rosenthal Rene Bouw Mimi Leung Paul Snell Richard D Mamelok 《Liver transplantation》2007,13(11):1570-1575
There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF required to provide a mycophenolic acid (MPA) exposure similar to that observed in adult liver transplant recipients receiving the recommended dose of MMF (target area under the plasma concentration-time curve from 0 to 12 hours [AUC(0-12)] for MPA of 29 mug.hour/mL in the immediate posttransplantation period and 58 microg x hour/mL after 6 months). A 12-hour pharmacokinetic profile was collected for 8 pediatric patients (mean age 20.9 months) on stable doses of MMF and CsA who had received a liver transplant > or = 6 months prior to entry and who had started on MMF within 2 weeks of transplantation. Mean MMF dosage was 285 mg/m(2) (range, 200-424 mg/m(2)). Of 8 patients, 7 had a MPA AUC(0-12) (range, 11.0-37.2 microg x hour/mL) well below the target. One patient had an AUC(0-12) > or = 58 microg x hour/mL but was considered an outlier and was excluded from analyses. Mean MPA AUC(0-12) and maximum plasma concentration values were 22.7 +/- 10.5 microg x hour/mL and 7.23 +/- 3.27 microg/mL, respectively; values normalized to 600 mg/m(2) (the approved pediatric dose in renal transplantation) were 47.0 +/- 21.8 microg x hour/mL and 14.5 +/- 4.21 microg/mL. In conclusion, assuming that MPA exhibits linear pharmacokinetics, when used in combination with CsA, a MMF dose of 740 mg/m(2) twice daily would be recommended in pediatric liver transplant recipients to achieve MPA exposures similar to those observed in adult liver transplant recipients. This finding should be confirmed by a prospective trial. 相似文献
63.
64.
65.
Yew Kuang Cheng Paul A Decker Megan M O'Byrne Catherine R Weiler 《Annals of allergy, asthma & immunology》2006,97(3):306-311
BACKGROUND: There are limited studies of large cohorts of patients with specific polysaccharide antibody deficiency (SPAD) syndrome. OBJECTIVE: To study the clinical and laboratory characteristics of patients with specific polysaccharide antibody deficiency syndrome. METHODS: We retrospectively studied 75 patients with total IgG levels of at least 500 mg/dL and fewer than 9 of 12 responses to vaccination with pneumococcal vaccine polyvalent. Exclusion criteria included an IgG level less than 500 mg/dL, established immunodeficiency syndrome, and secondary immunodeficiency. RESULTS: The most common clinical presentation was frequent infections (n = 69; 92%), including sinusitis (n = 53; 77%), pneumonia (n = 29; 42%), ear infections (n = 18; 26%), and bronchitis (n = 19; 28%). Other presentations were systemic infections (n = 5; 7%), autoimmune or rheumatic diseases (n = 6; 8%), and chronic diarrhea (n = 4; 5%). The median IgG2 level of patients with no response to pneumococcal vaccine polyvalent tended to be lower than that of patients with at least 1 response (150 vs 193 mg/dL, respectively; P = .06). There was no association between total IgG level (categorized as 500-600 or > or = 600 mg/dL) and frequency of infection (P = .43). Patients with fewer responses to pneumococcal vaccine polyvalent and a higher frequency of infections were more likely to receive intravenous immunoglobulin (IVIG) therapy (P = .01 and .003, respectively). Treatment with IVIG significantly reduced the number of infections (P < .001). CONCLUSION: Patients with no response to pneumococcal vaccine polyvalent tended to have lower IgG2 levels; those with fewer responses were more likely to receive IVIG therapy. 相似文献
66.
Paul Wan Sia Heng Tin Wui Wong Wai See Cheong 《European journal of pharmaceutical sciences》2003,19(5):381-393
The melt agglomeration process of lactose powder with hydrogenated cottonseed oil (HCO) as the hydrophobic meltable binder was investigated by studying the physicochemical properties of molten HCO modified by sucrose stearates S170, S770 and S1570. The size, size distribution, micromeritic and adhesion properties of agglomerates as well as surface tension, contact angle, viscosity and specific volume of molten HCO, with and without sucrose stearates, were examined. The viscosity, specific volume and surface tension of molten HCO were found to be modified to varying extents by sucrose stearates which are available in different HLB values and melt properties. The growth of melt agglomerates was promoted predominantly by an increase in viscosity, an increase in specific volume or a decrease in surface tension of the molten binding liquid. The agglomerate growth propensity was higher with an increase in inter-particulate binding strength, agglomerate surface wetness and extent of agglomerate consolidation which enhanced the liquid migration from agglomerate core to periphery leading to an increased surface plasticity for coalescence. The inclusion of high concentrations of completely meltable sucrose stearate S170 greatly induced the growth of agglomerates through increased specific volume and viscosity of the molten binding liquid. On the other hand, the inclusion of incompletely meltable sucrose stearates S770 and S1570 promoted the agglomeration mainly via the reduction in surface tension of the molten binding liquid with declining agglomerate growth propensity at high sucrose stearate concentrations. In addition to being an agglomeration modifier, sucrose stearate demonstrated anti-adherent property in melt agglomeration process. The properties of molten HCO and melt agglomerates were dependent on the type and concentration of sucrose stearate added. 相似文献
67.
In certain Japanese macaque (Macaca fuscata) populations, females routinely engage in same-sex courtship, mounting, and consortship activity. Drawing on behavioral,
biogeographic, and genetic research, we suggest that female homosexual behavior may be associated with genetically distinct
free-ranging populations of Japanese macaques. In addition, we briefly discuss the implications of this research for the evolution
of female homosexual behavior in this species. 相似文献
68.
69.
70.